S119: COMBINATION OF MINI-HYPER-CVD AND INOTUZUMAB (INO) FOLLOWED BY BLINATUMOMAB (BLINA) CONSOLIDATION IN PATIENTS WITH RELAPSED/REFRACTORY (R/R) ACUTE LYMPHOBLASTIC LEUKEMIA (ALL): A PHASE II TRIAL

• Fadi Haddad,
• Elias Jabbour,
• Cedric Nasnas,
• Nicholas Short,
• Walid Macaron,
• Marianne Zoghbi,
• Lewis Nasr,
• Nitin Jain,
• Emmanuel Almanza,
• Koji Sasaki,
• Farhad Ravandi,
• Partow Kebriaei,
• Xuelin Huang,
• Guillermo Garcia-Manero,
• Tapan Kadia,
• Sa Wang,
• Jovitta Jacob,
• Rebecca Garris,
• Susan O’brien,
• Hagop Kantarjian

Affiliations

Fadi Haddad

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Elias Jabbour

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Cedric Nasnas

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Nicholas Short

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Walid Macaron

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Marianne Zoghbi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Lewis Nasr

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Nitin Jain

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Emmanuel Almanza

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Koji Sasaki

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Farhad Ravandi

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Partow Kebriaei

2 The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation, Houston, United States

Xuelin Huang

3 The University of Texas MD Anderson Cancer Center, Biostatistics, Houston, United States

Guillermo Garcia-Manero

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Tapan Kadia

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Sa Wang

4 The University of Texas MD Anderson Cancer Center, Hematopathology Adm, Houston, United States

Jovitta Jacob

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Rebecca Garris

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States

Susan O’brien

5 Chao Family Comprehensive Cancer Center, University of California, Irvine

Hagop Kantarjian

1 The University of Texas MD Anderson Cancer Center, Leukemia, Houston, United States